경제
중도 성향
Ipsen is acquiring a Swiss biotech for up to $800 million to treat kidney transplant infections
Quartz
조회 0
이 뉴스, 어떠셨어요?
한 번의 탭으로 반응을 남겨요 · 로그인 불필요
The French drugmaker will pay 200 million euros upfront for Memo, whose lead drug targets a kidney transplant infection with no approved treatments ...
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'economy' 카테고리 뉴스
Quartz의 다른 기사
Former Intel chief architect's startup Oxmiq is raising $35 million to license AI chip architecture
Quartz
Abu Dhabi's MGX, backer of Anthropic and OpenAI, closed one of the biggest AI funds ever at $49 billion
Quartz
The Dow fell 184 points on Wednesday. The same stocks that drove it up all year are now pulling it down
Quartz